Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Skyline Medical Provides Update on Pending Merger with CytoBioscience
MINNEAPOLIS, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY ® System for automated, direct-to-drain medical fluid disposal, provides an update on progress toward completing its merger with CytoBioscience.
View HTML
Toggle Summary Skyline Medical Enters Innovative Technology Partnership with Intalere for STREAMWAY® System
Provides access to more than 90,000 members, including 3,733 hospitals
View HTML
Toggle Summary Skyline Medical Reports 2017 Second Quarter Financial Results
Conference call begins at 11:00 a.m. Eastern time tomorrow August 15
View HTML
Toggle Summary Skyline Medical Signs Definitive Merger Agreement With CytoBioscience
Conference call begins at 11:00 a.m. Eastern time on August 15 Definitive Merger Agreement signed, calling for issuance of Skyline common and preferred stock Skyline Medical expands revenue stream into growth markets with CytoBioscience for their ion channel screening and protein solubility
View HTML
Toggle Summary Skyline Medical Signs Binding Letter of Intent for Merger Transaction with CytoBioscience
MINNEAPOLIS, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY ® System for automated, direct-to-drain medical fluid disposal, announces the signing of a binding letter of intent for a merger transaction with
View HTML
Toggle Summary Skyline Medical Issues Letter to Stockholders
MINNEAPOLIS, June 29, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, today issued the following letter to stockholders, which may be found on its
View HTML
Toggle Summary Skyline Medical Announces CE Mark for the STREAMWAY® System
MINNEAPOLIS, June 15, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces that its European Authorized Representative, Emergo Europe B.V., has
View HTML
Toggle Summary Skyline Medical Reports 2017 First Quarter Financial Results
MINNEAPOLIS, May 15, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, reports financial results for the three months ended March 31, 2017 and provides a business update....
View HTML
Toggle Summary Skyline Medical to Hold Business Update Conference Call on May 16, 2017
MINNEAPOLIS, May 10, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc. (NASDAQ:SKLN) ("Skyline" or "the Company"), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, announced today that management will hold a conference call on May 16, 2017  to
View HTML
Toggle Summary Skyline Medical Reports 2016 Fourth Quarter and Full Year Financial Results and Provides Business Update
Conference call begins today at 4:30 p.m. Eastern time
View HTML